Cell and Continuum: Lifelong Learning in Neurology promote large-scale proteomics and diagnostic neuroimaging biomarkers for multiple sclerosis, emphasizing biomarker panels and imaging markers as key tools for MS research and care.
Large-scale proteomics across neurological disorders uncovers biomarker panel and targets in multiple sclerosis
Diagnostic Neuroimaging Biomarkers for Multiple Sclerosis
April #MultipleSclerosis and Related Disorders issue
available to all
This finding is one of many signals tracked across Healthcare. The live feed updates every few hours with new authority voices, debates, and emerging ideas.
← Back to Healthcare